Live Markets News

Loading market data...

markets

Weight loss drug maker sinks 25% after new safety data spooks investors

CNBCJune 8, 2026 at 12:41 PM

Read Full Article at CNBC →

Share:Post Share

While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.

This is a summary. For the full story, read the original article at CNBC.

Original source: CNBC

Related Articles

This latest rally may be a dead-cat bounce, warns normally bullish boutique

MarketWatchJune 9, 2026 at 9:20 AM

I’m 60, retired with $3 million. My fiancée, 55, has $1 million but plans to work for the next 10 years. Are we compatible?

MarketWatchJune 9, 2026 at 10:15 AM

A massive 16% market swing just rocked South Korea over 24 hours. The retail ‘ants’ holding the wheel are driving dangerously.

MarketWatchJune 9, 2026 at 10:16 AM

← Back to all articles